Makrigiannis Stamatios Cardiologist

PhD/ Thesis

“Prognostic value of C-reactive protein in patients submitted to reperfusion due to myocardial infarction”

Society Member

• Member of the Hellenic Cardiological Society (HCS)

• Member of the European Society of Cardiology (ESC)

• Member of the European Association of Percutaneous Cardiovascular Interventions

• Member of the Acute Cardiovascular Care Association

• Member of the Hellenic Medical Society for the Study of Risk Factors in Cardiovascular Disease

• Member of the Working group of Haemodynamic and Interventional Cardiology of the HSC

• Member of the Working group of Prevention and Rehabilitation of the HSC

AD-HOC REVIEWER for peer-reviewed international journals

• American Journal of Cardiology

• Journal of Critical Care

Professional Experience

• 1st Cardiology Department, HYGEIA Hospital (since 2013)

• Intensive Care Unit, “ΤΖΑΝΕΙΟ” General Hospital of Piraeus (2011-2013)

• Cardiology Department, “ΤΖΑΝΕΙΟ” General Hospital of Piraeus (2006 – 2010)

• 1st Department of Internal Medicine, “ΜΕΤΑXΑ” Hospital of Piraeus (2002-2004)

Clinical and Research Interest

Clinical Interest:

• Invasive treatment of coronary artery disease, especially using radial approach

• Acute and intensive cardiac care

• Heart Failure

• Antithrombotic treatment in atrial fibrillation and acute coronary syndromes

Research Interest: 

• Pathophysiologic mechanisms in coronary artery disease

• Optimization of transradial techniques in percutaneous interventions

• Biomarkers in acute coronary syndromes

• Antithrombotic treatment in atrial fibrillation

Awards

• Educational grant from the Hellenic Cardiological Society, 2013

• Moderated poster award “Dabigatran plasma concentration measurement in patients with AF: is it helpful for choosing the optimal dose?” Panhellenic Congress of Cardiology, Thessaloniki 2015.

• Research protocol funding, Hellenic Cardiological Society, 2014.

• Original research award “Clinical significance of different hsCRP measurements in the course of ST-elevation myocardial infarction” Panhellenic Congress of Cardiology, Athens 2013.

• Research protocol funding, Hellenic Cardiological Society, 2013.

• Original research award “C-reactive protein kinetics patients with ST-elevation acute myocardial infarction” HCS Working group seminars, Thessaloniki 2012.

Original research award “Characteristics of nonagenarians in Attica” HCS Working group seminars, Thessaloniki 2012.

Books

• “Non ST-segment elevation Acute Coronary Syndromes”. Book Chapter in “Καρδιολογικά Προβλήματα στην Κλινική Πράξη” [Challenges in Clinical Practice -in Greek] G.B Parisianos Medical Publications 2010. ISBN 978-960-99126-6-2

• “Atheromatous plaque – Diagnostic approach of the vulnerable plaque”. Book Chapter in “Καρδιομεταβολικός Κίνδυνος” [Cardiometabolic risk -in Greek] G.B Parisianos Medical Publications 2007. ISBN 978-960-89486-2-4

• “Introduction to the Cardiological Electronic Patient Record” In.Ι.Ε.S.Α.P Scientific Publications 2006. ISBN 960-89043-0-7

Recent Publications

• Gastrointestinal bleeding in patients receiving antiplatelet and anticoagulant therapy: practical guidance for restarting therapy and avoiding recurrences. Hellenic J Cardiol 2014;55:499-509.

• Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care 2014;29:697.e1-5.

• Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction. Am J Cardiol 2013;111: 26-30.

• Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Heart 2012;98:860-4.

• Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 2010;141:284-90.

• The impact of right ventricular involvement on the postdischarge long-term mortality in patients with acute inferior ST-segment elevation myocardial infarction. Angiology 2010;61:179-83.

• The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes. Clin Cardiol 2009;32:142-7.

• The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting. Am Heart J 2007;154:676-81.

• The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes. Int J Cardiol 2008;124:312-8.

• The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction. Heart 2007; 93:952-6